Suppr超能文献

和基因中的双等位基因突变可导致耳聋和(卵巢)脑白质营养不良。

Biallelic variants in and cause deafness and (ovario)leukodystrophy.

机构信息

From the Departments of Child Neurology (M.S.v.d.K., M. Breur) and Neuropathology (M. Bugiani, M. Breur), and Metabolic Unit, Department of Clinical Chemistry (M.I.M., D.E.C.S., G.S.S.), Amsterdam University Medical Centers and Amsterdam Neuroscience; Department of Functional Genomics (M.S.v.d.K.), Center for Neurogenomics and Cognitive Research, VU University, Amsterdam, the Netherlands; Genetic Metabolic Disorders Research Unit (L.G.R., J. Christodoulou), The Children's Hospital at Westmead, and Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, NSW, Australia; Architecture et Réactivité de l'ARN (J.R.-T., M.F.), UPR 9002, Université de Strasbourg, CNRS, Strasbourg, France; Institute for Molecular Bioscience (J. Crawford, C.S.), University of Queensland, St. Lucia, Queensland, Australia; Department of Neurology (J.v.G.), Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen; Department of Clinical Genetics (M.S.), Radboud University Medical Center, Nijmegen, the Netherlands; Departement Génétique Médicale (M.W.), Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHRU de Montpellier, France; Department of Clinical Genetics (Q.W.), Amsterdam University Medical Centers, the Netherlands; UF Innovation en Diagnostic Génomique des Maladies Rares (F.T.M.-T.), Centre Hospitalier Universitaire de Dijon, France; Radboud Center for Mitochondrial Medicine (R.J.R.), Translational Metabolic Laboratory, Department of Pediatrics, Radboud University Medical Center, Nijmegen, the Netherlands; Illumina Inc. (R.J.T.), San Diego, CA; AP-HP (B.K., F.M.), La Pitié-Salpêtrière University Hospital, Department of Genetics, Paris; INSERM U 1127 (B.K., C.D., F.M.), CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France; Murdoch Children's Research Institute (J. Christodoulou, C.S.), Parkville, Victoria, Australia; Department of Paediatrics (J. Christodoulou), University of Melbourne, Australia; Institute of Human Genetics (C.D.), University Hospital Essen, University Duisburg-Essen, Germany; and Sorbonne Universités (F.M.), Neurometabolic Clinical Research Group, Paris, France.

出版信息

Neurology. 2019 Mar 12;92(11):e1225-e1237. doi: 10.1212/WNL.0000000000007098. Epub 2019 Feb 8.

Abstract

OBJECTIVE

To describe the leukodystrophy caused by pathogenic variants in and , encoding mitochondrial leucyl transfer RNA (tRNA) synthase and mitochondrial and cytoplasmic lysyl tRNA synthase, respectively.

METHODS

We composed a group of 5 patients with leukodystrophy, in whom whole-genome or whole-exome sequencing revealed pathogenic variants in or . Clinical information, brain MRIs, and postmortem brain autopsy data were collected. We assessed aminoacylation activities of purified mutant recombinant mitochondrial leucyl tRNA synthase and performed aminoacylation assays on patients' lymphoblasts and fibroblasts.

RESULTS

Patients had a combination of early-onset deafness and later-onset neurologic deterioration caused by progressive brain white matter abnormalities on MRI. Female patients with pathogenic variants had premature ovarian failure. In 2 patients, MRI showed additional signs of early-onset vascular abnormalities. In 2 other patients with and pathogenic variants, magnetic resonance spectroscopy revealed elevated white matter lactate, suggesting mitochondrial disease. Pathology in one patient with pathogenic variants displayed evidence of primary disease of oligodendrocytes and astrocytes with lack of myelin and deficient astrogliosis. Aminoacylation activities of purified recombinant mutant leucyl tRNA synthase showed a 3-fold loss of catalytic efficiency. Aminoacylation assays on patients' lymphoblasts and fibroblasts showed about 50% reduction of enzyme activity.

CONCLUSION

This study adds and pathogenic variants as gene defects that may underlie deafness, ovarian failure, and leukodystrophy with mitochondrial signature. We discuss the specific MRI characteristics shared by leukodystrophies caused by mitochondrial tRNA synthase defects. We propose to add aminoacylation assays as biochemical diagnostic tools for leukodystrophies.

摘要

目的

描述分别由编码线粒体亮氨酰 tRNA(tRNA)合成酶和线粒体及细胞质赖氨酰 tRNA 合成酶的 和 种系变异引起的脑白质营养不良。

方法

我们组成了一个由 5 名脑白质营养不良患者组成的小组,在这些患者中,全基因组或全外显子组测序揭示了 或 中的致病性变异。收集了临床信息、脑部 MRI 和死后脑部尸检数据。我们评估了纯化的突变重组线粒体亮氨酰 tRNA 合成酶的氨酰化活性,并对患者的淋巴母细胞和成纤维细胞进行了氨酰化测定。

结果

患者具有早发性耳聋和随后的神经功能恶化,其特征为 MRI 上进行性脑白质异常。携带 种系变异的女性患者发生卵巢早衰。在 2 名患者中,MRI 显示出早发性血管异常的其他迹象。在另外 2 名携带 和 种系变异的患者中,磁共振波谱显示出升高的脑白质乳酸,提示存在线粒体疾病。一名携带 种系变异的患者的病理学显示出少突胶质细胞和星形胶质细胞原发性疾病的证据,表现为髓鞘缺失和星形胶质增生不足。纯化的重组突变亮氨酰 tRNA 合成酶的氨酰化活性显示出 3 倍的催化效率丧失。对患者的淋巴母细胞和成纤维细胞进行的氨酰化测定显示,酶活性降低了约 50%。

结论

本研究增加了 和 种系变异作为可能导致耳聋、卵巢早衰和伴有线粒体特征的脑白质营养不良的基因缺陷。我们讨论了由线粒体 tRNA 合成酶缺陷引起的脑白质营养不良的特定 MRI 特征。我们建议将氨酰化测定作为脑白质营养不良的生化诊断工具。

相似文献

引用本文的文献

4
Premature ovarian insufficiency.卵巢早衰。
Nat Rev Dis Primers. 2024 Sep 12;10(1):63. doi: 10.1038/s41572-024-00547-5.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验